These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11781234)

  • 1. Plasma levels of endothelial protein C receptor respond to anticoagulant treatment.
    Stearns-Kurosawa DJ; Swindle K; D'Angelo A; Della Valle P; Fattorini A; Caron N; Grimaux M; Woodhams B; Kurosawa S
    Blood; 2002 Jan; 99(2):526-30. PubMed ID: 11781234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants.
    Simioni P; Morboeuf O; Tognin G; Gavasso S; Tormene D; Woodhams B; Pagnan A
    Thromb Res; 2006; 117(5):523-8. PubMed ID: 15921724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of oral anticoagulant therapy by measuring plasma prothrombin fragment 1 + 2.
    Takahashi H; Wada K; Satoh N; Takakuwa E; Furuta R; Yoshino N; Shibata A
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):435-9. PubMed ID: 8329570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement.
    Yalçindağ FN; Batioğlu F; Ozdemir O; Cansizoğlu E; Eğin Y; Akar N
    Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies.
    Ducros E; Mirshahi SS; Faussat AM; Mirshahi P; Dimicoli S; Tang R; Pardo J; Ibrahim J; Marie JP; Therwath A; Soria J; Mirshahi M
    Cancer Med; 2012 Oct; 1(2):261-7. PubMed ID: 23342274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function.
    Liaw PC; Neuenschwander PF; Smirnov MD; Esmon CT
    J Biol Chem; 2000 Feb; 275(8):5447-52. PubMed ID: 10681521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis.
    Uitte de Willige S; Van Marion V; Rosendaal FR; Vos HL; de Visser MC; Bertina RM
    J Thromb Haemost; 2004 Aug; 2(8):1305-10. PubMed ID: 15304035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin.
    Holm J; Hillarp A; Erhardt L; Berntorp E
    Thromb Res; 1999 Nov; 96(3):205-12. PubMed ID: 10588463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of functional endothelial protein C receptor in human plasma.
    Kurosawa S; Stearns-Kurosawa DJ; Hidari N; Esmon CT
    J Clin Invest; 1997 Jul; 100(2):411-8. PubMed ID: 9218519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters.
    Jerkeman A; Astermark J; Hedner U; Lethagen S; Olsson CG; Berntorp E
    Thromb Res; 2000 Jun; 98(6):467-71. PubMed ID: 10899345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor.
    Fukudome K; Ye X; Tsuneyoshi N; Tokunaga O; Sugawara K; Mizokami H; Kimoto M
    J Exp Med; 1998 Apr; 187(7):1029-35. PubMed ID: 9529319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro.
    Ireland H; Konstantoulas CJ; Cooper JA; Hawe E; Humphries SE; Mather H; Goodall AH; Hogwood J; Juhan-Vague I; Yudkin JS; di Minno G; Margaglione M; Hamsten A; Miller GJ; Bauer KA; Kim YT; Stearns-Kurosawa DJ; Kurosawa S
    Atherosclerosis; 2005 Dec; 183(2):283-92. PubMed ID: 15921688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?
    Zeuthen EL; Lassen JF; Husted SE
    Thromb Res; 2003 Mar; 109(5-6):241-6. PubMed ID: 12818245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated soluble endothelial cell protein C receptor (sEPCR) levels in women with preeclampsia: a marker of endothelial activation/damage?
    Saposnik B; Peynaud-Debayle E; Stepanian A; Baron G; Simansour M; Mandelbrot L; de Prost D; Gandrille S
    Thromb Res; 2012 Feb; 129(2):152-7. PubMed ID: 21824644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cardiopulmonary bypass on thrombin generation and protein C pathway.
    Taneja R; Liaw PL; Al Ghazaly S; Priestap F; Murkin JM; Martin CM
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):35-40. PubMed ID: 23312776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsis.
    Guitton C; Gérard N; Sébille V; Bretonnière C; Zambon O; Villers D; Charreau B
    Intensive Care Med; 2011 Jun; 37(6):950-6. PubMed ID: 21394629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.
    Azzazene D; Al Thawadi H; Al Farsi H; Besbes S; Geyl C; Mirshahi S; Pardo J; Faussat AM; Jeannette S; Therwath A; Pujade-Lauraine E; Mirshahi M
    Int J Oncol; 2013 Oct; 43(4):1011-8. PubMed ID: 23877403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.